Dan Michalovitz
- Oncology top 1%
- Molecular Biology top 5%
- Biotechnology top 0.5%
- Genetics top 5%
- Cancer Research top 5%
- Co-authors
- Moshe OrenOrna HalevyDaniel EliyahuS EliyahuAvri Ben‐Ze'evCesare VescoJames M. PipasAbraham Amsterdam
- Topics
- Virus-based gene therapy research (7 papers)Cancer-related Molecular Pathways (5 papers)Cancer Research and Treatments (3 papers)
- Cited by
- BiotechnologyOncologyCancer Research
- Partner nations
- IsraelUnited States
In The Last Decade
Dan Michalovitz
10 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 81
- Oncology 1.7k
- Molecular Biology 1.4k
- Biotechnology 589
- Genetics 390
- Cancer Research 358
Countries citing papers authored by Dan Michalovitz
This map shows the geographic impact of Dan Michalovitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Michalovitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Michalovitz more than expected).
Fields of papers citing papers by Dan Michalovitz
This network shows the impact of papers produced by Dan Michalovitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Michalovitz. The network helps show where Dan Michalovitz may publish in the future.
Co-authorship network of co-authors of Dan Michalovitz
This figure shows the co-authorship network connecting the top 25 collaborators of Dan Michalovitz. A scholar is included among the top collaborators of Dan Michalovitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Michalovitz. Dan Michalovitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 98 | |
| 2 | Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53breakdown → | 695 |
| 3 | 210 | |
| 4 | Wild-type p53 can inhibit oncogene-mediated focus formation.breakdown → | 608 |
| 5 | 2 | |
| 6 | 56 | |
| 7 | 20 | |
| 8 | 42 | |
| 9 | 296 | |
| 10 | 171 |
About Dan Michalovitz
Dan Michalovitz is a scholar working on Biotechnology, Oncology and Genetics, having authored 10 papers that have together received 2.2k indexed citations. Recurring topics across this work include Virus-based gene therapy research (7 papers), Cancer-related Molecular Pathways (5 papers) and Cancer Research and Treatments (3 papers). The work is most often cited by research in Biotechnology (589 citations), Oncology (1.7k citations) and Cancer Research (358 citations). Dan Michalovitz has collaborated with scholars based in Israel and United States. Frequent co-authors include Moshe Oren, Orna Halevy, Daniel Eliyahu, S Eliyahu, Avri Ben‐Ze'ev, Cesare Vesco, James M. Pipas and Abraham Amsterdam. Their work appears in journals such as Nature, Science and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.